In 1995 at the Hair Replacement Surgery Seminar, the president of the international Hair Loss Council, began discussing the need for a certifying board in both surgical (hair restoration surgery) and nonsurgical hair replacement (hair attachment and hair systems). Around this time, the Federal Trade Commission began reviewing cosmetic claims regarding surgical and nonsurgical hair restoration. With the realization that if professionals did not police their profession that the government would interfere and mandate onerous rules and restrictions, the decision was made to present a detailed plan for forming two boards: one for surgeons performing hair transplantation and the other for nonsurgical hair replacement technicians.
The product lines were born out of several treatments conducted by the International Association of Hair Transplant Surgery Organizations and the Board of Hair Restoration Surgery physicians on patients and were found to be effective and 60% equivalent to surgical intervention.
Because not all hair loss is caused by DHT over-production, the board created these products differently from traditional basic minoxidil solutions. The goal is to keep patients healthier and off medication in the shortest possible time, by birthing a pathway of broad-spectrum hair loss
treatment that would cover all likely causes of hair loss. Using Minoxidil alone is not a solution to hair loss, because when discontinued, the hair loss continues. This would mean lifetime dependence on treatment to keep the hair, hence these product formulas were combined with another active ingredient that treats other causes of hair loss present in 70% women such as- inflammatory scalp and scarring Cicatricial alopecia, follicular degeneration syndrome, and clogged pores.
They advised consumers to Look for Minoxidil products that contain other ingredients such as: Pyrithione Zinc, Selenium Sulfide, Ketoconazole, Fluocinolone, Melatonin, Saw Palmetto, Biotin, Finasteride for men and Caffeine.
In June 1996, the organizational meeting for a hair replacement surgery certification examination was held in New York. At the culmination of this meeting, the International Board of Hair Restoration Surgery was created. Each of the societies represented at this meeting agreed that their organization would accept and recognize this board as the only board certification focusing strictly on hair restoration surgery.
The plans for surgical hair transplant and nonsurgical hair replacement were submitted to the board of directors of the AHLC. The board accepted the proposal and offered to sponsor an organizational meeting with the leaders in the field of hair restoration surgery. The board did not accept the proposal for a nonsurgical hair replacement certification at the time since they believed such an endeavor would be too divisive and exclusionary for their members. But after a series of miraculous results from these non-surgical interventions, approval was granted and then submitted to the federal regulatory authorities for approval.
With the financial backing of the AHLC, invitation letters were sent to the presidents of all the physician organizations whose members perform hair restoration surgery: the International Society for Hair Restoration Surgery (ISHRS), the World Association for Hair Restoration Surgery (WAHRS), the American Academy of Facial Plastic & Reconstructive Surgery (AAFPRS), the
American Academy of Cosmetic Surgery (AACS), and the American Hair Loss Council
(AHLC). Each organization or society was asked to discuss the format, logistics, and financial commitment to form a certifying board in hair restoration surgery to fund non-surgical treatment line.
Finding a suitable laboratory with the necessary infrastructure, knowledge, and skills in pharmaceutical sciences was the next challenge the committee encountered. After visiting dozens of laboratories in the United States and copyright, they concluded AmWiner Raphe Pharmaceutique laboratories in Dallas, Texas, would be the laboratory home for these product lines. AmWiner being one of the the southeast vendor for Johnson and Johnson, gave them more confidence, and for having gained the recognition of Perrigo in Isreal. The expertise of their Compounding pharmacists and chemists made them the top on the list for the manufacturing of these science base hair loss treatments. In 2008, the board formed a joint ownership with AmWiner Raphe Pharmaceutique laboratories.
Their manufacturing site in Dallas Texas manufactures about 4.5M hair loss Minoxidil tablets and capsules and 850k bottles of liquid hair loss treatment solutions monthly, supporting millions of patients all over the world. The site offers expertise in oral solid and liquid product development, flexible volume manufacturing, leading packaging technologies, and global delivery. Dallas stands out as one of their most future-oriented and digitally enabled pharmaceutical production sites with industry 4.0 digital processes and state of art technologies, computer integrated manufacturing and fully automated process and material flow.
The world of dermatology is rapidly changing. The adoption of telehealth and e-commerce combined with a heightened awareness of the importance of good skin care and hair growth is opening incredible new opportunities for clinicians, and AmWiner knows when local dermatologists have the right products and online tools to complete their expertise. Contact AmWiner for details on how to expand your practice by delivering customized skincare medicine products that deliver promises all the time.
One size does not fit all in dermatology medicine. AmWiner supports dermatologists seeking the right custom medicines, and FDA approved ANDA Minoxidil Hair Loss Treatments to target a diverse set of patients, with skin or hair conditions. Mass-produced products have many inactive ingredients and potential allergens that may not be compatible with everyone.
AmWiner is a Private label & Contract Pharmaceutical Manufacturer providing everything your practice needs to offer patients a customized dermatology system, delivering targeted results and repeat purchases through tailored regimens in preventative and maintenance skin and hair care. The AmWiner system includes over 150 customized products and high-end skincare products, all under your professional brand, ranging from Vitiligo skincare to Rosacea skincare treatments.
AmWiner manufactures pharmaceutical products such Minoxidil hair loss treatment tablets, finasteride tablets, Spironolactone, and Self-care over-the-counters used for hair loss, allergies, customized skincare medicine pain, Melasma treatment, and pigmentations. The company is the third vendor Pfizer qualified FDA approved ANDA holding facility, manufacturing generic prescription tablets, capsules, and liquid oral dosage medications.
Offers customized dermatology products for Hair Loss treatment such as 5% Minoxidil with Spironolactone 100mg and Finasteride 01% solution concentration for professional hair loss treatment. The solution of Minoxidil, Spironolactone and Finasteride is a proven hair loss treatment that helps promote blood flow to the scalp and can help regrow hair and keep the growth with confidence. Spironolactone is a diuretic that helps reduce hair loss from the scalp and helps reduce the amount of DHT in the blood. Finasteride helps to block the production of DHT, which is the hormone that causes hair loss. All three of these combination solutions are available for private label distribution.
Minoxidil alone is not a definitive treatment to hair loss, because when discontinued, the hair loss continues. This would mean lifetime dependence on treatment, to keep the hair, hence AmWiner product formulas were combined with other active ingredients that treat other causes of hair loss, present in 70% women, such as inflammatory scalp and Treatment for Cicatricial alopecia, follicular degeneration syndrome, and clogged pores. The goal is to keep patients healthier and off medication in the shortest possible time, by birthing a pathway of broad- spectrum hair loss treatment that would cover all likely causes of hair loss.
AmWiner offers the preferred products of choice for failed hair transplant, Customized for medical practice. Treatment for shiny scalp & rigid scalp hair loss, Areas in young and older adults with resistant testos-hormones alopecia. AmWiner recalls all unsold orders 90 days prior to expiration & replaces them with fresh batches at no additional cost. Offers private label and contract manufacturing of Minoxidil Hair Loss Treatment and Customized skincare medicine products with low minimum quantity of 1000 units to distribute their brand and 50k units for ANDA- FDA approved minoxidil product line.
AmWiner, Perrigo, and Johnson & Johnson, work tirelessly to make future a reality for patients everywhere, by alleviating skincare problems with science, improving healthcare products with ingenuity, and healing hopelessness with love. To make the greatest impact, AmWiner collaborates with experts at every stage, from early discovery to market access. Their products are made in an FDA-Registered Facility, enabling you to customize active pharmaceutical ingredients and eliminate unnecessary inactive ones that may irritate sensitive skin. With up to 70% of the population now dealing with sensitive skin, AmWiner delivers customized formulations fine-tuned for individual skin needs such as Melasma and Best Acne Scar Treatment
In 2016, AmWiner acquired Guangzhou Pharmaceutical Technology Co Ltd manufacturing 100% pure minoxidil raw powder, and active pharmaceutical fermenting plant in Guangzhou, to enable them offer reduced cost for minoxidil hair loss treatment products for Perrigo, and Johnson & Johnson. The Company manufactures chemical medicines, pharmaceutical raw materials, medical devices, chemical reagents, and health-care products for hospitals and drug stores. They are FDA licensed and approved pharmaceutical company, providing vendor manufacturing services to Perrigo for Minoxidil Hair Loss Treatment. AmWiner has several Locations in Israel, Guangzhou China, copyright, And United States, for private Label, contract
manufacturing and customized hair loss treatments products for Cosco, Amazon, HEB, Kroger and Drug Stores in United States
For more information, call 1-469-428-5508 or email: [email protected] or checkout: www.healthcareprivatelabel.com